Vertex Pharmaceuticals Incorporated (VRTX)
$507.00-0.60%Close
SELLBEAR · day 25
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV13.9%–78.5%
- Market cap
- $128.7B
- Beta
- 0.32
- P/E (TTM)
- 29.00
- IV-%ile
- 15
- IV ATM
- 23.8%
- Short % float
- 1.78%
- Days to cover
- 4.2
- SI change
- -4.5%
- 1W
- +0.70%
- 1M
- -1.64%
- vs SPY 1W
- +0.27%
- vs SPY 1M
- -3.70%
Industry peers
FMP comparable companies · ranked by market cap
- ALNYSELLAlnylam Pharmaceuticals, Inc.$31.1BRECOVERYQ 28$232.68-2.43%
- BBIOSELLBridgeBio Pharma, Inc.$12.8BRECOVERYQ 18$65.35+0.61%
- BMRNSELLBioMarin Pharmaceutical Inc.$10.6BBEARQ 12$54.80+1.08%
- IONSSELLIonis Pharmaceuticals, Inc.$7.5BRECOVERYQ 8$45.28-3.56%
- PTCTSELLPTC Therapeutics, Inc.$5.4BRECOVERYQ 18$64.70-2.75%
- CRSPSELLCRISPR Therapeutics AG$5.1BBEARQ 20$53.39-3.45%
- BEAMBUYBeam Therapeutics Inc.$2.6BRECOVERYQ 13$25.70-2.22%
- SRPTSELLSarepta Therapeutics, Inc.$1.9BRECOVERYQ 13$17.85-2.30%
- NTLABUYIntellia Therapeutics, Inc.$1.8BRECOVERYQ 3$13.07-3.75%
- RAREBUYUltragenyx Pharmaceutical Inc.$1.5BRECOVERYQ -6$15.48-1.16%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VRTX?
- LOPJLB’s latest quantitative signal on Vertex Pharmaceuticals Incorporated (VRTX) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is VRTX in?
- Vertex Pharmaceuticals Incorporated (VRTX) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Vertex Pharmaceuticals Incorporated (VRTX) do?
- Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for CF patients, including SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which target specific mutations within the cystic fibrosis transmembrane conductanc…